It can lead to neuropathy, megaloblastic anemia, and pernicious anemia, [2] [13] causing symptoms including fatigue, paresthesia, depression, cognitive decline, ataxia, and even irreversible nerve damage
03Wie wirkt GHK-Cu auf molekularer Ebene
Vial sizes ran from 5mg to 48mg, and the 12.8% stockout rate is the third-highest in the deep-dive group
Disclaimer: This list is informational and based on publicly available data, accreditation records, patient reviews, and pharmacy industry knowledge
FDA Status BPC-157s FDA status remains not approved for medical use or over-the-counter sale. In April 2026, compounding restrictions were adjusted, but the peptide still cannot be prescribed or sold for human/animal consumption
Cyanocobalamin is more common and has a shorter body retention